Company Overview and News

1
Outpatient & Home Healthcare Stock Outlook: Prospects Bright

2018-07-11 zacks
Artificial intelligence (AI) has been a roaring success in healthcare, taking the outpatient and home healthcare space by storm as well!
UNP DGX AMED CHE

0
Outpatient Market Gains on Social Awareness: 3 Stocks in Focus

2018-07-05 zacks
The price that the United States has to pay for being one of the most socially advanced nations is high-risk emergencies from sexual offence, depression and obsessive compulsive disorder. The country relentlessly puts up a fight against these medical issues that call for privacy, anonymity and home-based or Outpatient care. That’s not all. The recent national epidemic of Opioid abuse and President Trump’s fresh “tough on crime” policies to curb it are likely to increase the need for Outpatient rehab centers.
DB DGX BIOS CHE DLPH

14
LHCG or CHE: Which Is the Better Value Stock Right Now?

2018-07-02 zacks
Investors looking for stocks in the Medical - Outpatient and Home Healthcare sector might want to consider either LHC Group (LHCG - Free Report) or Chemed (CHE - Free Report) . But which of these two companies is the best option for those looking for undervalued stocks? Let's take a closer look.
LHCG CHE

12
CHE / Chemed Corp. CHEMED CORP. 8-K (Current Report)

2018-06-22 sec.gov
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549
CHE

11
CHE / Chemed Corp. null

2018-06-20 sec.gov
begin 644 filename1.pdf M)5!$1BTQ+C8-)>+CS],-"C,R(# @;V)J#3P\+T9I;'[email protected]*R&AKU^'[email protected]=#_]W M6D#HND*E^*3 7D36\$('9^)"?C#1L>$L4318BTI(T2+F6&6(V:?:D3:>//#B M0O8/R%H>OV ,9-/L E.6)@=J#C29"/L,@P;[email protected]%T";+:;@8%S3(U\\+ZY+ M7!U3M]\MUM6I/)6'S=YYW[\%& "[email protected]#0IE;F1S=')E86T-96YD;V)J#3,S M(# @;V)J#3P\+T9I;'1EJ'5!:[email protected]
CHE

150
Walgreens Boots' Retail Pharmacy Strong Despite Several Woes

2018-06-20 zacks
On Jun 19, we issued an updated research report on Walgreens Boots Alliance, Inc. (WBA - Free Report) . We are currently looking forward to the company’s modified Rite Aid contract, expected to benefit the company in the long run. The stock carries a Zacks Rank #3 (Hold).
RAD WBA ISRG CHE ILMN

22
Here's Why You Should Add Amedisys (AMED) to Your Portfolio

2018-06-19 zacks
Amedisys, Inc. (AMED - Free Report) has been gaining investor confidence on consistent positive results. Over the past six months, the company’s share price has outperformed its industry. The stock has gained 62.9% compared with 13.5% growth recorded by the industry. Also, the company has outperformed the S&P 500’s 3.8% increase.
WBA AMED CHE ILMN

25
New Strong Buy Stocks for June 18th

2018-06-18 zacks
Chemed Corporation (CHE - Free Report) : This company that provides hospice and palliative care services has seen the Zacks Consensus Estimate for its current year earnings increasing 3.4% over the last 60 days.
HD LXFR CHE SC

13
LHCG or CHE: Which Is the Better Value Stock Right Now?

2018-06-14 zacks
Investors looking for stocks in the Medical - Outpatient and Home Healthcare sector might want to consider either LHC Group (LHCG - Free Report) or Chemed (CHE - Free Report) . But which of these two stocks presents investors with the better value opportunity right now? Let's take a closer look.
LHCG CHE

23
Envision Healthcare's (EVHC) Ratings on Review for Downgrade

2018-06-12 zacks
Credit ratings giant Moody's Investors Service has placed Envision Healthcare Corporation’s ((EVHC - Free Report) ratings on review for downgrade. This followed the announcement that KKR, a private equity firm, will acquire the company for $9.9 billion in cash. The outlook also remains under review. The acquisition is expected to be completed during the fourth quarter of 2018. The ratings put under review by Moody’s include the B1 Corporate Family Rating, B1-PD Probability of Default Rating and all debt instrument ratings.
AAC AMED CHE

27
The Zacks Analyst Blog Highlights: Oshkosh, Chemed and Urban Outfitters

2018-06-12 zacks
Chicago, IL – June 12, 2018 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include Oshkosh Corp. (OSK - Free Report) , Chemed Corp. (CHE - Free Report) and Urban Outfitters (URBN - Free Report) .
MS.PRE MS.PRF MS.PRG WTW CHE MS.PRA VSTO MS.PRI OSK MS.PRK TRI URBN LYV MS CVA

29
The World Cup Begins: Global Week Ahead

2018-06-11 zacks
We have lots of global events this week, counted in terms of soccer games, a historic diplomatic summit, and three major monetary policy meetings.
DB HSC MS.PRI OSK MS.PRK MS.PRE MS.PRF MS.PRG URBN MS CHE MS.PRA

50
Cooper Companies (COO) Q2 Earnings & Revenues Beat Estimates

2018-06-08 zacks
The Cooper Companies, Inc. (COO - Free Report) posted second-quarter fiscal 2018 adjusted earnings of $2.86 per share, which beat the Zacks Consensus Estimate by 1.1%. Earnings also increased 14.4% on a year-over-year basis.
COO UNP BAX ISRG CHE

17
Unemployment Falls to 18-Year Low: 6 Winning Picks

2018-06-04 zacks
Nearly an hour before its release, President Trump tweeted that he was “looking forward” to May’s jobs data. Ultimately, the report was able to live up to investors’ expectations, heightened primarily by Trump’s comments. The unemployment rate declined to the lowest level witnessed since April 2000. Job additions also increased substantially.
MTZ DDS JEC SCVL ENSG CHE

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

2018-07-17 - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

2018-07-17 - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

2018-07-16 - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...

Silicon Investor Message Boards

This table lists all message boards related to CHE / Chemed Corp. on message board site Silicon Investor.

Da_cheifs vomitorium Microcap Kitchen Canadian Stocks
Diabetic Kitchen Heart Attacks, Cancer and strokes. Preventative approaches
Stock Watcheru0027s Thread / Pix of the Week (POW) Chesapeake Gold
The Microcap Kitchen: Stocks 5�� to $5 2016 Kitchen Cookoff , Sizzling Stocks of the Year Contest
Chevron Chesapeake Gold (CKG.V)
CUSIP: 16359R103